Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-246519
Filing Date
2024-10-29
Accepted
2024-10-29 16:05:28
Documents
1
Group Members
PANACEA INNOVATION LTDPANACEA VENTURE HEALTHCARE FUND II GP COMPANY, LTD.PANACEA VENTURE HEALTHCARE FUND II, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d846894dsc13ga.htm SC 13G/A 86491
  Complete submission text file 0001193125-24-246519.txt   88226
Mailing Address 9620 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address
Huang James (Filed by) CIK: 0001573160 (see all company filings)

Type: SC 13G/A

Mailing Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025
Business Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025 86 10 6561 8789
CASI Pharmaceuticals, Inc. (Subject) CIK: 0001962738 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-94039 | Film No.: 241405686
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)